Evidence map›Paper›PMID 33217932›Full record

ArticleCancers2020

Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors.

Laura Pignata, Orazio Palumbo, Flavia Cerrato, Basilia Acurzio, Enrique de Álava, Josep Roma, Soledad Gallego, Jaume Mora, Massimo Carella, Andrea Riccio and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. ICF1-Syndrome-AssociatedBiomolecules · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Epigenetic Alterations in Inborn Errors of Immunity.Journal of clinical medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Laura PignataDepartment of Environmental Biological and Pharmaceutical Sciences and Technologies, University of Campania 'Luigi Vanvitelli', 81100 Caserta, Italy.
Orazio PalumboDivision of Medical Genetics, Fondazione IRCCS "Casa Sollievo della Sofferenza", 71013 San Giovanni Rotondo (FG), Italy.ORCID 0000-0001-6583-3482
Flavia CerratoDepartment of Environmental Biological and Pharmaceutical Sciences and Technologies, University of Campania 'Luigi Vanvitelli', 81100 Caserta, Italy.ORCID 0000-0003-3794-3021
Basilia AcurzioInstitute of Genetics and Biophysics 'Adriano Buzzati-Traverso' CNR, 80131-Napoli, Italy.
Enrique de ÁlavaDepartment of Pathology, Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, 41013 Seville, Spain.ORCID 0000-0001-8400-046X
Josep RomaGroup of Translational Research in Child and Adolescent Cancer, Vall d'Hebron Research Institute-Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Soledad GallegoGroup of Translational Research in Child and Adolescent Cancer, Vall d'Hebron Research Institute-Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Jaume MoraPediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain.
Massimo CarellaDivision of Medical Genetics, Fondazione IRCCS "Casa Sollievo della Sofferenza", 71013 San Giovanni Rotondo (FG), Italy.
Andrea RiccioDepartment of Environmental Biological and Pharmaceutical Sciences and Technologies, University of Campania 'Luigi Vanvitelli', 81100 Caserta, Italy.ORCID 0000-0001-7990-3576
Gaetano VerdeDepartment of Environmental Biological and Pharmaceutical Sciences and Technologies, University of Campania 'Luigi Vanvitelli', 81100 Caserta, Italy.ORCID 0000-0003-4768-0165
University of Campania "Luigi Vanvitelli" · ITCasa Sollievo della Sofferenza · ITUniversitat Autònoma de Barcelona · ESHospital Sant Joan de Déu Barcelona · ESInstitute of Genetics and Biophysics · ITInstituto de Biomedicina de Sevilla · ES

Funding

Associazione Italiana per la Ricerca sul Cancro IG18671Fondazione Telethon GGP1513Ministero dell'Istruzione, dell'Università e della Ricerca JHLY35
6 · The paper itself

Abstract

The embryonal renal cancer Wilms tumor (WT) accounts for 7% of all children's malignancies. Its most frequent molecular defect is represented by DNA methylation abnormalities at the imprinted 11p15.5 region. Multiple imprinted methylation alterations dictated by chromosome copy-number variations have been recently demonstrated in adult cancers, raising the question of whether multiple imprinted loci were also affected in WT. To address this issue, we analyzed DNA methylation and chromosome profiles of 7 imprinted loci in 48 WT samples. The results demonstrated that methylation abnormalities of multiple imprinted loci occurred in 35% of the cases, but that they were associated with either chromosome aberrations or normal chromosome profiles. Multiple imprinted methylation changes were correlated with tumor stage and presence of metastasis, indicating that these epimutations were more frequent in highly aggressive tumors. When chromosome profiles were affected, these alterations were extended to flanking cancer driver genes. Overall, this study demonstrates the presence of multiple imprinted methylation defects in aggressive WTs and suggests that the mechanism by which they arise in embryonal and adult cancers is different.

Indexed as

chromosome aberrationsDNA methylationgenomic imprintingnephroblastoma

Identifiers

PMID33217932
PMCPMC7698742
OpenAlexW3098510313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.